Substituted 1,5-naphthyridine azolidinones as CDK inhibitors

Details for Australian Patent Application No. 2006232747 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Liu, Jin-Jun

Agent Davies Collison Cave

Pub. Number AU-B-2006232747

PCT Pub. Number WO2006/106046

Priority 60/668,246 05.04.05 US

Filing date 24 March 2006

Wipo publication date 12 October 2006

Acceptance publication date 12 April 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/106046 Priority application(s): WO2006/106046

12 April 2012 Application Accepted

  Published as AU-B-2006232747

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006232773-Sulfonylpyrroles as histone deacetylase inhibitors

2006232693-Method for seismic acquisition on the seabed, guiding equipment, seismic acquisition equipment and seismic acquisition system for the implementation of this method